CTAG2 and neoplasm: CD4+ Tregs that are specific for the LAGE1 and ARTC1 tumor antigens have been identified in melanoma, and EBNA1 P561-573 and P607-619 peptide-specific CD4+ Tregs have been identified in PBMCs from healthy donors [39,40].